Brazil has approved the use of the world’s first single-dose dengue vaccine. The vaccine, developed in Brazil, is authorized for people aged 12 to 59 who are at risk of dengue infection. The vaccine underwent eight years of trials before approval, showing strong safety and effectiveness results. It was developed locally with assistance from a […]